Consultoría en Alimentos de acuerdo a la FDA, Mercosur, CAA, HACCP y HARPC.
Auditorías en Alimentos de acuerdo a la FDA, Mercosur, CAA, HACCP y HARPC.
Capacitaciones Oficiales de acuerdo a la FDA, Mercosur, CAArgentino.
FSVP. Como Instructor Líder estoy habilitado para realizar las auditorias que la Norma exige.

Jorge Descalzo

FDA Form483 & Warning Letter

FDA Form 483 & Warning Letter

AffairIf you received a Form 483 or a Warning Letter from the FDA, my team and I have extensive experience in resolving the problem.

We are part of the Food Safety and Quality Organization.

One way that the Food and Drug Administration (FDA) protects public health and ensures compliance with the Food, Drug and Cosmetic Act is by conducting inspections of facilities that manufacture, process or pack FDA-regulated products.  At the conclusion of an investigation, a site may be issued a Form 483 or a Warning Letter.

After a Form 483 is issued and the inspector completes the Establishment Inspection Report, the agency may issue a Warning Letter. A Warning Letter indicates that higher FDA officials have reviewed the observations and that a serious violation may exist. This formal notification allows for voluntary and prompt corrective action. 

FDA Form 483 Frequently Asked Questions, and what is a Warning Letter?

Q: When is an FDA Form 483 issued?

A: An FDA Form 483 is issued to firm management at the conclusion of an inspection when an investigator(s) has observed any conditions that in their judgment may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts. FDA investigators are trained to ensure that each observation noted on the FDA Form 483 is clear, specific and significant. Observations are made when in the investigator’s judgment, conditions or practices observed would indicate that any food, drug, device or cosmetic has been adulterated or is being prepared, packed, or held under conditions whereby it may become adulterated or rendered injurious to health.

Q: What is the purpose of an FDA Form 483?

A: The FDA Form 483 notifies the company’s management of objectionable conditions. At the conclusion of an inspection, the FDA Form 483 is presented and discussed with the company’s senior management. Companies are encouraged to respond to the FDA Form 483 in writing with their corrective action plan and then implement that corrective action plan expeditiously.

Q: Is the FDA Form 483 intended to be an all-inclusive list of every possible deviation from law and regulation?

A: No, it’s not. The FDA Form 483 is a report which does not include observations of questionable or unknown significance at the time of the inspection. There may be other objectionable conditions that exist at the firm that are not cited on the FDA Form 483. FDA investigators are instructed to note only what they saw during the course of the inspection. Companies are responsible to take corrective action to address the cited objectionable conditions and any related non-cited objectionable conditions that might exist.

Q: How is the FDA Form 483 shared with the company?

A: FDA Form 483s are discussed with a company’s management at the conclusion of the inspection. Each observation is read and discussed so that there is a full understanding of what the observations are and what they mean.

Q: What are the implications of the FDA Form 483 for agency enforcement and what happens next?

A: The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations. The FDA Form 483 is considered, along with a written report called an Establishment Inspection Report, all evidence or documentation collected on-site, and any responses made by the company. The Agency considers all of this information and then determines what further action, if any, is appropriate to protect public health.

What is a Warning Letter?

When FDA finds that a manufacturer has significantly violated FDA regulations, FDA notifies the manufacturer. This notification is often in the form of a Warning Letter.

The Warning Letter identifies the violation, such as poor manufacturing practices, problems with claims for what a product can do, or incorrect directions for use. The letter also makes clear that the company must correct the problem and provides directions and a timeframe for the company to inform FDA of its plans for correction. FDA then checks to ensure that the company’s corrections are adequate.

Empresas e instituciones con las cuales he colaborado y colaboro.

1-pitusa
10-coca-cola-argentina
11-comercial-mexicana
12-corlasa
13-cooperativa-obrera
14-countdown
15-danone
16-deals
18-dia
19-dollar-tree-canada
2-bargain
20-dollar-tree-usaDT
21-el-corte-ingles
21-el-machetazo
22-falabella
24-falabella-peru
25-familia-zuccardi
26-family-dollar
27-farmacity
28-granja-tres-arroyos
29-grupo-casino
3-big-lots
30-grupo-cencosud-argentina
31-grupo-disco
32-grupo-jumbo-chile
33-grupo-hospital-espaniol
34-hoyts-cines
35-iapc
36-iram
37-IHA
38-kasdorf
39-kmart
4-ba-vending
40-la-anonima
41-la-serenisima
42-libertad-supermercados
43-lojas-brasileras
44-mc-donalds
45-mesbla
46-mida-puerto-rico
47-NRA
48-NAHA
49-ocasa
5-caritas
50-plaza-automercados-venezuela
51-publix
52-restaurantes-campo-portenio
53-restaurantes-capisci
54-revista-actualidad-en-supermercados
55-riera
56-sai-global
57-sai-global
58-sedanos
59-soriana
6-grupo-carrefour-argentina
60-stock-supermercados-paraguay
61-subway
63-supermercados-amigo
64-fidalga-bolivia
65-la-sirena-dominicana
66-nacional-mexico
67-supermercados-pueblo
69-tata-uruguay
7-carrefour-brasil
70-toledo
71-unimarc-chile
72-vea-argentina
73-greenbrier
77-walmart-brasil
79-walmart-el-salvador-y-costa-rica
8-carrefour-colombia
80-walmart-mexico-y-centro-america
81-walmart-peru
82-walmart-usa
83-winndixie
86-woolworths-australia
88-woolworths-south-africa
9-carrefour-mexico

food safety